Evidence map›Paper›PMID 31396494›Full record

ArticleFrontiers in pediatrics2019

MiR-223-3p Alleviates Vascular Endothelial Injury by Targeting IL6ST in Kawasaki Disease.

Xiang Wang, Yue Yue Ding, Ye Chen, Qiu Qin Xu, Guang Hui Qian, Wei Guo Qian, Lei Cao, Wan Ping Zhou, Miao Hou, Hai Tao Lv

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The effect of miR-223-3p on endothelial cells in coronary artery disease.In vitro cellular & developmental biology. Animal · 2024
    Article
  12. Diagnosis, Progress, and Treatment Update of Kawasaki Disease.International journal of molecular sciences · 2023
    Review
  13. Review
  14. Review
  15. MicroRNAs in cardiovascular diseases.Medical review (2021) · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xiang WangDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Yue Yue DingDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Ye ChenDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Qiu Qin XuDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Guang Hui QianDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Wei Guo QianDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Lei CaoDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Wan Ping ZhouDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Miao HouDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Hai Tao LvDepartment of Cardiology, Children's Hospital of Soochow University, Suzhou, China.
Soochow University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IL6STKawasaki diseaseMicroRNA-223-3pSTAT3vascular endothelial damage

Identifiers

PMID31396494
PMCPMC6667785
OpenAlexW2964178306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.